Detalhe da pesquisa
1.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
2.
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-XL /BCL-2 inhibition with navitoclax.
Cancer
; 129(22): 3535-3545, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584267
3.
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Am J Hematol
; 98(2): 272-281, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309981
4.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Blood
; 122(11): 1923-34, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926298
5.
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
Blood
; 122(17): 3034-44, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970380
6.
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
Lancet Haematol
; 9(6): e434-e444, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576960
7.
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Blood Cancer Discov
; 1(1): 48-67, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974613
8.
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
J Hematol Oncol
; 6: 21, 2013 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497456
9.
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.
J Clin Invest
; 123(10): 4144-57, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23999433
10.
BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
Leuk Lymphoma
; 52 Suppl 1: 30-44, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21299458
11.
Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis.
Blood
; 111(7): 3760-9, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18216295
12.
Demonstration of a method for the direct determination of polycyclic aromatic hydrocarbons in submerged sediments.
Environ Sci Technol
; 37(6): 1189-97, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12680674